Netscientific Share Discussion Threads

[blakieboy7] 25/3/2022 21:18

Yeah got it. What a waste of money that was to produce and send

[samsung2020] 25/3/2022 20:07

Evening folks. Did anyone get the annual NSCI newsletter through the post? Nothing major on it!

[loafofbread] 24/3/2022 23:11

Study info updated last week.
Status: Recruiting
End of study Dec2022

Thanks to tqhussain on lse.

Good news in that the study is still ongoing and the number of patients has gone down.

[loafofbread] 23/3/2022 19:35

Difficult to understand the disconnect to asset value here.

PDSB and cash equate to our M Cap.

You then have on top of that.

EMV £3.5M
Proaxis £3.5M
Glycotest £11.0M
Epibone £700K
Sofant £300K
Q Bot £1.0M

Which is another £20M or approx £1.00 a share.

Granted we have had sfa news from Glycotest, but they did manage to sell 1% for £300k last year.

Results must be soon so massive upside and very little downside.

[kingston78] 23/3/2022 17:10

The advance of the share price from 50 p has been slower than I expected. However, its momentum remains positive and it will soon reach my first target of 70 p before hitting 90 p in quick succession.

[lazygun] 21/3/2022 16:10

ive added a few today

l

[senttothegallows] 21/3/2022 15:35

It is an awful long way from where it should be IMHO £1 would not be expensive IMHO

[blakieboy7] 21/3/2022 15:06

Nice rise today

[blakieboy7] 18/3/2022 15:23

PDSB up another 4%

[blakieboy7] 18/3/2022 07:52

PDSB closed up at $6.34 fwiw

[kingston78] 14/3/2022 16:19

The share price has now cleared the 60 p level, being the right shoulder of the small V shape on the chart. The slow stochastics and momentum are ticking upwards, now at 20, so there is a long way to go still. More importantly, the MACD signal line is about to cross the normal MACD line, and once it has crossed (upwards) the share price will steam ahead completing the large V shape to the 90 p level.

Good luck all.

[kingston78] 14/3/2022 09:24

All technical indicators are moving upwards now. The share price should be moving up in unison with the indicators.

[blakieboy7] 14/3/2022 08:41

Nice to see a bit of blue

[blakieboy7] 12/3/2022 10:45

I've just received a copy of the Q1 newsletter in the post! This was unnecessary as I've already read it

[kingston78] 10/3/2022 10:36

Yesterday's chart action shows an overwhelming reversal from the downtrend.
This morning's chart shows a continuation of positive trend. This is the best time to buy. I reiterate my short term target of 70 p quickly followed by a 90 p secondary target.

[kingston78] 09/3/2022 20:53

According to the website MSN.com and based on six analysts as of 3/3/2022 there is one buy and five strong buy for PDSB, with one year target price of US$ 19.71. This is in contrast to the current price of US$5.68 (up 11% on the day 9th March 2022).

It may be coincidental, both the share prices of PSBD and NSCI have fallen so much over the last ten months. It would appear that both have reached the lowest point and are now rising.

Every action has an equal and opposite reaction. They will rise as quickly as they fall.

[kingston78] 09/3/2022 14:57

The share chart is beginning to show a reversal of the downtrend. I have a first target of 70 p and a second target of 90 p, both of which should be achieved in the short term. Shares move up and down. I just don't believe that those investors at the placing at 130 p last June will lose money over a longer term. I have added some more shares in my portfolio.

PDSB has made the following announcement today:
Provided by GlobeNewswire
Mar 9, 2022 1:00 PM GMT
FLORHAM PARK, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® and Infectimune™ T-cell activating technologies, today announced the Company will release financial results for the three- and twelve-month periods ended December 31, 2021, on Wednesday, March 23, 2022, before the market opens. Following the release, management will host a conference call to review the financial results and provide a business update.

[simonparker5] 09/3/2022 10:57

Agreed, I think it is time for a nice big top up down here.

[k1ngkonggb] 07/3/2022 13:53

FFS...NSCI....WTF is going on.

[blakieboy7] 07/3/2022 13:51

WTAF! 12% down

[blakieboy7] 04/3/2022 19:02

Makes absolutely no sense